Crossmark

Lenalidomide combined with R-CHOP (R2-CHOP) in the treatment of newly diagnosed double-expressor diffuse large B-cell lymphoma: a prospective phase II clinical trial

Crossref DOI link: https://doi.org/10.1038/s41408-025-01229-5

Published Online: 2025-02-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Yizhen https://orcid.org/0000-0002-1320-7364
Zhang, Qunling

Lv, Fangfang

Liu, Xiaojian

Ji, Dongmei

Xia, Zuguang

Jin, Jia

Tao, Rong

Zhang, Wenhao

Li, Xiaoqiu

Zhang, Shengjian

Wang, Zezhou

Wang, Jiachen

Hong, Xiaonan

Cao, Junning https://orcid.org/0000-0002-3146-9413
License Information

Text and Data Mining valid from 2025-02-25

Version of Record valid from 2025-02-25
More Information

Article History

Received: 4 October 2024

Revised: 16 January 2025

Accepted: 10 February 2025

First Online: 25 February 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below